Gender Male
From June 1974 to June 2010, Roderick Budd, CPA, CA practiced as a public accountant at Ernst & Young LLP. Mr. Budd currently serves as the chairman of the audit committee of the board of directors of Telesta Therapeutics Inc., a biopharmaceutical company focused on oncology, and Bedrocan Cannabis Corp., a producer of pharmaceutical-grade
medicinal cannabis. Mr. Budd also serves as chairman of the board of directors and chairman of the audit committee of the board of directors of Immunotec Inc., a nutritional and wellness products company. Mr. Budd holds a Bachelor of Commerce degree from Concordia University, a graduate diploma in accounting from McGill University and is a CPA, CA in Canada.
